Skip to main content
Premium Trial:

Request an Annual Quote

Institut Pasteur Korea, DNDi Partner in Neglected Diseases Screening Effort

NEW YORK (GenomeWeb News) – The international non-profit Drugs for Neglected Diseases Initiative (DNDi) and the Institut Pasteur Korea (IP-K) will collaborate to screen for and examine molecules that may be used as new treatments for certain "neglected" diseases, IP-K said today.

The two-year research agreement will focus on studying molecules that could be developed into treatments for leishmaniasis, which kills around 20,000 to 30,000 people per year, and Chagas disease, which affects around seven to eight million people every year.

Under the collaboration, IP-K will use in its PhenomicScreen technology to search for potentially promising drug candidates, and both groups will provide the other with access to their global networks with the aim of finding partners to establish new joint research programs, IP-K said.

IP-K's Screening Technology Platform Group uses the PhenomicScreen to identify novel compounds against infectious and chronic diseases.

This agreement expands on an initial partnership between the two groups, which began in 2007 and led to the development of new assays that identified new hit compounds against leishmaniasis, IP-K said.

DNDi's long-term objective is to deliver 11 to 13 new treatments by 2018 for tropical diseases like leishmaniasis and Chagas disease, as well as malaria, pediatric HIV, human African trypanosomiasis, and specific helminth infections.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.